73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
New chemical weapon to combat cancer

New chemical weapon to combat cancer

by University of GenevaMultipolar melanoma cells stained for centrosomes (gamma-tubulin in red, centrin in green) and DNA (DAPI in blue). Scale bar represents 5 µm. Credit: UNIGEUNIGE researchers

New chemical weapon to combat cancer

by University of GenevaMultipolar melanoma cells stained for centrosomes (gamma-tubulin in red, centrin in green) and DNA (DAPI in blue). Scale bar represents 5 µm. Credit: UNIGEUNIGE researchers
Longer exclusive breastfeeding may lower risk for childhood hematologic cancers

Longer exclusive breastfeeding may lower risk for childhood hematologic cancers

by Lori SolomonExclusive breastfeeding duration of at least three months may decrease the risk for childhood hematologic cancers, according to a study published online March 26 inJAMA Network Op

Longer exclusive breastfeeding may lower risk for childhood hematologic cancers

by Lori SolomonExclusive breastfeeding duration of at least three months may decrease the risk for childhood hematologic cancers, according to a study published online March 26 inJAMA Network Op
Fewer than 3 of 10 women cite diet when asked how to reduce chances of breast cancer

Fewer than 3 of 10 women cite diet when asked how to reduce chances of breast cancer

by Physicians Committee for Responsible MedicineCredit: Pixabay/CC0 Public DomainJust 28% of U.S. women are aware that a healthful diet can lower the risk of developing breast cancer, according to a j

Fewer than 3 of 10 women cite diet when asked how to reduce chances of breast cancer

by Physicians Committee for Responsible MedicineCredit: Pixabay/CC0 Public DomainJust 28% of U.S. women are aware that a healthful diet can lower the risk of developing breast cancer, according to a j
Research predicts cancer patients' response to chemotherapy agent cisplatin

Research predicts cancer patients' response to chemotherapy agent cisplatin

by Cleveland ClinicVisual representation of convergent evolution in animals and convergent phenotypes in tumors.aBirds and bats are genomically disparate, but both have individually e

Research predicts cancer patients' response to chemotherapy agent cisplatin

by Cleveland ClinicVisual representation of convergent evolution in animals and convergent phenotypes in tumors.aBirds and bats are genomically disparate, but both have individually e
Lu(a)minar flow odyssey—using the power of water and light in early leukemia diagnostics

Lu(a)minar flow odyssey—using the power of water and light in early leukemia diagnostics

by Polish Academy of SciencesOpto-hydrodynamic tweezers. (a) and (b) Schematic illustrations of the top view and side view of OHT, respectively, along with the major various forces acting on the

Lu(a)minar flow odyssey—using the power of water and light in early leukemia diagnostics

by Polish Academy of SciencesOpto-hydrodynamic tweezers. (a) and (b) Schematic illustrations of the top view and side view of OHT, respectively, along with the major various forces acting on the
Wide variation in bowel cancer rates after colonoscopies in England

Wide variation in bowel cancer rates after colonoscopies in England

by British Medical JournalBowel cancer survivor John Barnes. Credit: University of LeedsSubstantial variation exists between colonoscopy providers in rates of bowel cancer up to three years after

Wide variation in bowel cancer rates after colonoscopies in England

by British Medical JournalBowel cancer survivor John Barnes. Credit: University of LeedsSubstantial variation exists between colonoscopy providers in rates of bowel cancer up to three years after
Researcher leads first in-human multiple myeloma study with over 90% response rate

Researcher leads first in-human multiple myeloma study with over 90% response rate

by Indiana University School of MedicineMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Indiana University Melvin and Bren

Researcher leads first in-human multiple myeloma study with over 90% response rate

by Indiana University School of MedicineMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Indiana University Melvin and Bren
Examining the pesticides that may increase cancer risk in children

Examining the pesticides that may increase cancer risk in children

by Anna Novoselov,University of California, Los AngelesEstimated Odds Ratios and 95% Confidence Intervals from the Hierarchical Logistic Regression Model for all cases combined. Credit:Int

Examining the pesticides that may increase cancer risk in children

by Anna Novoselov,University of California, Los AngelesEstimated Odds Ratios and 95% Confidence Intervals from the Hierarchical Logistic Regression Model for all cases combined. Credit:Int
Woman sues L'Oreal over claim hair straightener spurred uterine cancer

Woman sues L'Oreal over claim hair straightener spurred uterine cancer

by Cara MurezA Missouri woman has sued L'Oréal and several other beauty product companies, alleging that their hair-straightening products caused heruterine cancer.Thelawsuitclai

Woman sues L'Oreal over claim hair straightener spurred uterine cancer

by Cara MurezA Missouri woman has sued L'Oréal and several other beauty product companies, alleging that their hair-straightening products caused heruterine cancer.Thelawsuitclai
Trial of cell-based therapy for high-risk lymphoma leads to FDA breakthrough designation

Trial of cell-based therapy for high-risk lymphoma leads to FDA breakthrough designation

by Krista Conger,Stanford UniversityScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDCAR-T cell therapy, which

Trial of cell-based therapy for high-risk lymphoma leads to FDA breakthrough designation

by Krista Conger,Stanford UniversityScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDCAR-T cell therapy, which
FDA Approves Two Cell-Based SCD Gene Therapies

FDA Approves Two Cell-Based SCD Gene Therapies

February 2024The U.S. Food and Drug Administration (FDA) approved exagamglogene autotemcel (exa-cel) and lovotibeglogene autotemcel (lovo-cel) for the treatment of sickle cell disease (SCD) in patient

FDA Approves Two Cell-Based SCD Gene Therapies

February 2024The U.S. Food and Drug Administration (FDA) approved exagamglogene autotemcel (exa-cel) and lovotibeglogene autotemcel (lovo-cel) for the treatment of sickle cell disease (SCD) in patient
Team introduces new approach in cancer therapy with innovative mechanism-of-action for ferroptosis induction

Team introduces new approach in cancer therapy with innovative mechanism-of-action for ferroptosis induction

byHelmholtz Zentrum MünchenFSP1 condensates in green induced by icFSP1 surrounding a blue nucleus. Credit: Toshitaka NakamuraA team of researchers led by Dr. Marcus Conrad from Helmholtz Munich

Team introduces new approach in cancer therapy with innovative mechanism-of-action for ferroptosis induction

byHelmholtz Zentrum MünchenFSP1 condensates in green induced by icFSP1 surrounding a blue nucleus. Credit: Toshitaka NakamuraA team of researchers led by Dr. Marcus Conrad from Helmholtz Munich